Twist Bioscience Corporation (TWST) IV/HV History
Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.
Twist Bioscience Corporation (TWST) operates in the Healthcare sector, specifically the Medical - Diagnostics & Research industry, with a market capitalization near $3.39B, listed on NASDAQ, employing roughly 923 people, carrying a beta of 2.23 to the broader market. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Led by Emily Marine Leproust, public since 2018-10-31.
Snapshot as of May 15, 2026.
- Spot Price
- $48.87
- ATM IV
- 91.4%
- HV 20-Day
- 68.6%
- HV 60-Day
- 73.7%
- IV Rank
- 42.5%
- IV Percentile
- 69.4%
As of May 15, 2026, Twist Bioscience Corporation (TWST) ATM implied volatility is 91.4%. 20-day realized volatility is 68.6%, producing an IV-HV spread of +22.8 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 42.5%.
How TWST iv/hv history Data Feeds Strategy Selection
Strategy selection on Twist Bioscience Corporation options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 91.4% and dealer gamma exposure is negative, so dealer hedging amplifies directional moves. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how implied vs realized volatility is reported and how to read the data →
Frequently asked TWST iv/hv history questions
- Is TWST options pricing rich or cheap right now?
- As of May 15, 2026, Twist Bioscience Corporation (TWST) ATM IV is 91.4% against 20-day realized volatility of 68.6%. IV rank is 42.5%. TWST options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 22.8 vol points.
- What is the TWST variance risk premium?
- The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. TWST is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
- What does TWST IV rank mean for strategy selection?
- IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. TWST's current rank of 42.5% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.